12-OH-17,18-Epoxyeicosatetraenoic acid alleviates eosinophilic airway inflammation in murine lungs.

BACKGROUND: Asthma is characterized by airway inflammation and obstruction with eosinophil infiltration into the airway. Arachidonic acid, an omega-6 fatty acid, is metabolized into cysteinyl leukotriene with pro-inflammatory properties for allergic inflammation, whereas the omega-3 fatty acid eicosapentaenoic acid (EPA) and its downstream metabolites are known to have anti-inflammatory effects. In this study, we investigated the mechanism underlying the counter-regulatory roles of EPA in inflamed lungs. METHODS: Male C57BL6 mice were sensitized and challenged by ovalbumin (OVA). After EPA treatment, we evaluated the cell count of Bronchoalveolar lavage fluid (BALF), mRNA expressions in the lungs by q-PCR, and the amounts of lipid mediators by liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based lipidomics. We investigated the effect of the metabolite of EPA by in vivo and in vitro studies. RESULTS: Eicosapentaenoic acid treatment reduced the accumulation of eosinophils in the airway and decreased mRNA expression of selected inflammatory mediators in the lung. Lipidomics clarified the metabolomic profile in the lungs. Among EPA-derived metabolites, 12-hydroxy-17,18-epoxyeicosatetraenoic acid (12-OH-17,18-EpETE) was identified as one of the major biosynthesized molecules; the production of this molecule was amplified by EPA administration and allergic inflammation. Intravenous administration of 12-OH-17,18-EpETE attenuated airway eosinophilic inflammation through downregulation of C-C chemokine motif 11 (CCL11) mRNA expression in the lungs. In vitro, this molecule also inhibited the release of CCL11 from human airway epithelial cells stimulated with interleukin-4. CONCLUSION: These results demonstrated that EPA alleviated airway eosinophilic inflammation through its conversion into bioactive metabolites. Additionally, our results suggest that 12-OH-17,18-EpETE is a potential therapeutic target for the management of asthma.

International cooperation with Islamabad Children's Hospital, Pakistan: the JICA project.

The experience gained during 7 years of cooperation between the Japan International Cooperation Agency (JICA) and the Islamabad Children's Hospital (JICA-ICH project, July 1986-June 1993) is described. Islamabad Children's Hospital achieved the goals of the project and became a centre for excellence in health care, education and research for children, fulfilling the objectives of the project. This achievement was evaluated as one of the most successful projects in medical cooperation ever performed by JICA by a third party evaluation team. The problems arising and the lessons experienced through the process are discussed. The importance of the role which should be undertaken by pediatricians in international cooperation with developing countries is emphasized.

PIP: The Japan International Cooperation Agency (JICA) provided the funds for the construction of the Pakistan Institute of Medical Sciences' children's hospital (ICH) in Islamabad. JICA worked with ICH between July 1986 and June 1993. Japan sent 67 specialists to ICH and Pakistan sent 34 counterparts to Japan for training. JICA also provided equipment. The high mineral content (e.g., calcium) of the local water damaged equipment. There is no competent Pakistani medical engineer to repair the equipment. The project has addressed the shortage of nurses. Feed back and horizontal discussions among physicians and nurses or paramedics are uncommon. Exposure to colleagues in Japan changed behavior of the Pakistani counterparts returning from Japan, resulting in greater competence and in them behaving responsibly, being loyal, and adopting problem saving attitudes. Inadequate understanding of management by most counterparts, except physicians or senior level professionals, hurt the function and efficacy of ICH. ICH was governed by budget controls of the Pakistan Ministry of Health and of the Pakistan Institute of Medical Sciences, which sometimes kept ICH from receiving essential operating costs. ICH had too many outpatients and limited space for the clinical laboratory. A filter-clinic set up in a new OPD building solved the space problem. A too bureaucratic policy initially hindered the project. Despite these obstacles, ICH is a center of excellence in health care, education, and research. 82 physicians and 113 nurses work at ICH. ICH carries out much maternal and child health activity. ICH serves as a postgraduate teaching institution for pediatricians and for pediatric nurses. The Canadian International Development Agency evaluated the JICA ICH project and rated ICH as one of the most successful JICA medical projects.

Outbreaks of paralytic poliomyelitis and polio surveillance in Shandong province of China.

Widespread outbreaks of paralytic poliomyelitis occurred in Shandong province, China, starting from 1988. In 1989, 484 cases were recorded, which was the peak during the past 4 years. Although emergency immunization with trivalent oral poliovirus vaccine (OPV) was carried out in selected counties in 1989 and 1990, control of the outbreak was not satisfactory. OPV mass immunization campaigns were introduced to cover the whole province in early 1991, and the number of patients with paralytic poliomyelitis decreased to 95. In addition to this new immunization strategy, we began to construct new polio surveillance systems. These were a network for case-negative reporting and an immediate reporting system of acute flaccid paralysis (AFP). As for the case-negative reporting, presently more than 90% of counties have been reporting presence or absence of new AFP cases. Monitoring of AFP immediate reporting has also shown a gradual improvement in several aspects. These polio surveillance activities are crucial to polio eradication programme management.